The knockdown of p53 attenuated the reduction in cell viability as well as the induction of cell death and activation of the caspase pathway in RG7112-treated glioma stem cells (Figure 4A–C), suggesting that p53 was required for the apoptotic death of glioma stem cells induced by the inhibition of MDM2. The gene discussed is TP53; the disease is central nervous system cancer.